Chian Ri-Cheng, Xu Yixin, Keilty Dana
Department of Obstetrics and Gynecology, McGill University, 687 Pine Avenue West, H3A 1A1, Montreal, Canada.
Methods Mol Biol. 2017;1568:33-44. doi: 10.1007/978-1-4939-6828-2_3.
Current freezing technology, especially the vitrification method, has markedly improved oocyte survival rate after warming, and the pregnancy rate is comparable to that achieved with fresh oocytes. However, most groups report using oocytes matured in vivo for vitrification. Although immature oocytes can be vitrified successfully, clinical outcomes do not reach that of vitrification of matured oocytes. The current literature suggests that oocytes should be vitrified at mature metaphase II (M-II) stage following IVM rather than at the immature germinal vesicle (GV) stage, because the potential for oocyte maturation is reduced when vitrification is performed on immature oocytes at the GV stage.
目前的冷冻技术,尤其是玻璃化冷冻法,已显著提高了卵母细胞解冻后的存活率,其妊娠率与新鲜卵母细胞相当。然而,大多数研究团队报告称使用的是体内成熟的卵母细胞进行玻璃化冷冻。虽然未成熟卵母细胞能够成功进行玻璃化冷冻,但临床结局不如成熟卵母细胞玻璃化冷冻的效果。当前文献表明,卵母细胞在体外成熟(IVM)后应在成熟的中期II(M-II)阶段进行玻璃化冷冻,而非在未成熟的生发泡(GV)阶段,因为在GV阶段对未成熟卵母细胞进行玻璃化冷冻会降低其成熟的潜力。